Membership Directory
Mercury Therapeutics, Inc.
Category: Drug Development
Phone: + (781) 932-1125
Fax: + (781) 932-8140
Website: http://www.mtipharm.com
Location: Woburn, MA
Mercury Therapeutics, Inc. (“MTI”) is an early stage biopharmaceutical company focused on developing breakthrough treatments for cancer and metabolic disease. MTI’s expertise lies in its ability to generate small molecule drugs against targets in the AMP Kinasesignal transduction pathway that control tumor growth and energy metabolism. The Company recently licensed its lead compound in type 2 diabetes, MT63-78, to Debiopharm, SA of Lausanne, Switzerland and is developing additional compounds internally for indications in oncology.
Back to list